日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

胰腺癌特有的隐蔽抗原是 T 细胞识别的目标

Ely Zackery A, Kulstad Zachary J, Gunaydin Gurcan, Addepalli Sudarsana, Verzani Eva K, Casarrubios Marta, Clauser Karl R, Wang Xilin, Lippincott Isabelle E, Louvet Cedric, Schmitt Thomas, Kapner Kevin S, Agus Miles P, Hennessey Connor J, Cleary James M, Hadrup Sine R, Klaeger Susan, Su Jennifer, Jaeger Alex M, Wolpin Brian M, Raghavan Srivatsan, Smith Eric L, Greenberg Philip D, Aguirre Andrew J, Abelin Jennifer G, Carr Steven A, Jacks Tyler, Freed-Pastor William A

Development of antigen multimers for detection and evaluation of CAR T cells

开发用于检测和评估CAR T细胞的抗原多聚体

Friis, Rasmus U W; Ormhøj, Maria; Krüger-Jensen, Cecilie S; Pardo, Carlos Rodriguez; Halldórsdóttir, Hólmfridur Rósa; Barden, Markus; Kristensen, Nikolaj P; Ramanathan, Keerthana; Hansen, Mikkel R; Abken, Hinrich; Hadrup, Sine R

Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells.

干扰素-α促进胰腺β细胞中新抗原的形成和优先的HLA-B限制性抗原呈递

Carré Alexia, Zhou Zhicheng, Perez-Hernandez Javier, Samassa Fatoumata, Lekka Christiana, Manganaro Anthony, Oshima Masaya, Liao Hanqing, Parker Robert, Nicastri Annalisa, Brandao Barbara, Colli Maikel L, Eizirik Decio L, Göransson Marcus, Morales Orlando Burgos, Anderson Amanda, Landry Laurie, Kobaisi Farah, Scharfmann Raphael, Marselli Lorella, Marchetti Piero, You Sylvaine, Nakayama Maki, Hadrup Sine R, Kent Sally C, Richardson Sarah J, Ternette Nicola, Mallone Roberto

Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness

作者更正:基本的免疫致癌性权衡决定了驱动突变的适应度

Hoyos, David; Zappasodi, Roberta; Schulze, Isabell; Sethna, Zachary; de Andrade, Kelvin César; Bajorin, Dean F; Bandlamudi, Chaitanya; Callahan, Margaret K; Funt, Samuel A; Hadrup, Sine R; Holm, Jeppe S; Rosenberg, Jonathan E; Shah, Sohrab P; Vázquez-García, Ignacio; Weigelt, Britta; Wu, Michelle; Zamarin, Dmitriy; Campitelli, Laura F; Osborne, Edward J; Klinger, Mark; Robins, Harlan S; Khincha, Payal P; Savage, Sharon A; Balachandran, Vinod P; Wolchok, Jedd D; Hellmann, Matthew D; Merghoub, Taha; Levine, Arnold J; Łuksza, Marta; Greenbaum, Benjamin D

Fundamental immune-oncogenicity trade-offs define driver mutation fitness

基本的免疫致癌性权衡决定了驱动突变的适应性

Hoyos, David; Zappasodi, Roberta; Schulze, Isabell; Sethna, Zachary; de Andrade, Kelvin César; Bajorin, Dean F; Bandlamudi, Chaitanya; Callahan, Margaret K; Funt, Samuel A; Hadrup, Sine R; Holm, Jeppe S; Rosenberg, Jonathan E; Shah, Sohrab P; Vázquez-García, Ignacio; Weigelt, Britta; Wu, Michelle; Zamarin, Dmitriy; Campitelli, Laura F; Osborne, Edward J; Klinger, Mark; Robins, Harlan S; Khincha, Payal P; Savage, Sharon A; Balachandran, Vinod P; Wolchok, Jedd D; Hellmann, Matthew D; Merghoub, Taha; Levine, Arnold J; Łuksza, Marta; Greenbaum, Benjamin D

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials

利用嵌合抗原受体改造T细胞以对抗血液肿瘤:临床试验最新进展

Ormhøj, Maria; Abken, Hinrich; Hadrup, Sine R

NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data

NetTCR-2.0 利用配对的 TCRα 和 β 序列数据,能够准确预测 TCR-肽结合情况。

Montemurro, Alessandro; Schuster, Viktoria; Povlsen, Helle Rus; Bentzen, Amalie Kai; Jurtz, Vanessa; Chronister, William D; Crinklaw, Austin; Hadrup, Sine R; Winther, Ole; Peters, Bjoern; Jessen, Leon Eyrich; Nielsen, Morten

The T cell differentiation landscape is shaped by tumour mutations in lung cancer.

肺癌中肿瘤突变会影响T细胞分化格局

Ghorani Ehsan, Reading James L, Henry Jake Y, Massy Marc Robert de, Rosenthal Rachel, Turati Virginia, Joshi Kroopa, Furness Andrew J S, Ben Aissa Assma, Saini Sunil Kumar, Ramskov Sofie, Georgiou Andrew, Sunderland Mariana Werner, Wong Yien Ning Sophia, Mucha Maria Vila De, Day William, Galvez-Cancino Felipe, Becker Pablo D, Uddin Imran, Oakes Theres, Ismail Mazlina, Ronel Tahel, Woolston Annemarie, Jamal-Hanjani Mariam, Veeriah Selvaraju, Birkbak Nicolai J, Wilson Gareth A, Litchfield Kevin, Conde Lucia, Guerra-Assunção José Afonso, Blighe Kevin, Biswas Dhruva, Salgado Roberto, Lund Tom, Bakir Maise Al, Moore David A, Hiley Crispin T, Loi Sherene, Sun Yuxin, Yuan Yinyin, AbdulJabbar Khalid, Turajilic Samra, Herrero Javier, Enver Tariq, Hadrup Sine R, Hackshaw Allan, Peggs Karl S, McGranahan Nicholas, Chain Benny, Swanton Charles, Quezada Sergio A

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

立体定向消融放射治疗(SABR)联合免疫疗法(L19-IL2)与标准疗法治疗IV期非小细胞肺癌患者的疗效比较:一项多中心、随机、对照、开放标签的II期临床试验(ImmunoSABR)。

Lieverse, Relinde I Y; Van Limbergen, Evert J; Oberije, Cary J G; Troost, Esther G C; Hadrup, Sine R; Dingemans, Anne-Marie C; Hendriks, Lizza E L; Eckert, Franziska; Hiley, Crispin; Dooms, Christophe; Lievens, Yolande; de Jong, Monique C; Bussink, Johan; Geets, Xavier; Valentini, Vincenzo; Elia, Giuliano; Neri, Dario; Billiet, Charlotte; Abdollahi, Amir; Pasquier, David; Boisselier, Pierre; Yaromina, Ala; De Ruysscher, Dirk; Dubois, Ludwig J; Lambin, Philippe

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

T细胞受体库的空间异质性反映了肺癌的突变图谱。

Joshi, Kroopa; de Massy, Marc Robert; Ismail, Mazlina; Reading, James L; Uddin, Imran; Woolston, Annemarie; Hatipoglu, Emine; Oakes, Theres; Rosenthal, Rachel; Peacock, Thomas; Ronel, Tahel; Noursadeghi, Mahdad; Turati, Virginia; Furness, Andrew J S; Georgiou, Andrew; Wong, Yien Ning Sophia; Ben Aissa, Assma; Sunderland, Mariana Werner; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Birkbak, Nicolai J; Wilson, Gareth A; Hiley, Crispin T; Ghorani, Ehsan; Guerra-Assunção, José Afonso; Herrero, Javier; Enver, Tariq; Hadrup, Sine R; Hackshaw, Allan; Peggs, Karl S; McGranahan, Nicholas; Swanton, Charles; Quezada, Sergio A; Chain, Benny